ISU
Home
ISURF/OIPTT
Home
ISURFtech
Home
Advanced
Search
RSS
Feeds
Challenge Strains of Mycoplasma bovis
Category(s):
For Information, Contact:
Dario Valenzuela
Senior Commercialization Manager, Life Sciences
515-294-4740
licensing@iastate.edu
Web Published:
12/7/2015
ISURF #
3876
Development Stage:
Description:
There is a need to have highly pathogenic strains of Mycoplasma bovis to challenge cattle that are vaccinated with vaccine candidates against Mycoplasma bovis in order to test the efficacy of the vaccine candidates. ISURF is making available for licensing on a non-exclusive basis two Mycoplasma bovis strains (M23, 428E) suitable to help validate Mycoplasma bovis vaccine candidates and for diagnostics.  The strains were recovered from two different outbreaks of Mycoplasma bovis pneumonia and polyarthritis in Iowa cattle.  Description of one of the outbreaks has been published.  Description of the pathogenic potential of both strains has been presented at conferences.  One of the strains (M23) has been used as standard strain for cattle infection reports, and as wild-type to develop various mutants with gene disruptions or deletions.

Advantage:
• Well-characterized strains
• Suitable for diagnostics and vaccine validation

Application:
Research, Diagnostics, Vaccine Validation Studies

References:
Rosenbusch, R. F. Bovine mycoplasmosis. Proceedings of the 34th Annual Convention of the American Association of Bovine Practitioners, pp 49-52, Vancouver, British Columbia, 2001.
Patent Information:
*To see the full version of the patent(s), follow the link below, then click on "Images" button.


Direct Link: